Virginia Rivero Buceta

Title: Virginia Rivero Buceta: Innovator in Protein Kinase Inhibition

Introduction

Virginia Rivero Buceta is a notable inventor based in Spain, recognized for her contributions to the field of medicinal chemistry. Her work primarily focuses on the development of compounds that serve as protein kinase inhibitors, which are crucial in the treatment of various diseases, including cancer.

Latest Patents

Virginia Rivero Buceta holds a patent titled "Condensed Tricyclic Compounds As Protein Kinase Inhibitors." This patent describes compounds of formula I, wherein R1, R2, R3, R4, R5, R6, R7a, and R7b have specific meanings as detailed in the description. These compounds are particularly useful in treating diseases where the inhibition of a protein or lipid kinase, such as CDK8 and/or Haspin kinase, is desired. The compounds also include pharmaceutically acceptable esters, amides, solvates, or salts, making them versatile in therapeutic applications.

Career Highlights

Virginia Rivero Buceta is affiliated with the Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III, where she contributes to groundbreaking research in oncology. Her innovative work has positioned her as a key figure in the development of new therapeutic strategies against cancer.

Collaborations

Virginia collaborates with esteemed colleagues, including Joaquin Pastor Fernandez and Sonia Martinez Gonzalez, who share her commitment to advancing cancer research and treatment methodologies.

Conclusion

Virginia Rivero Buceta's contributions to the field of protein kinase inhibition highlight her role as an innovator in cancer treatment. Her work continues to pave the way for new therapeutic options that could significantly impact patient care.